S‐adenosylmethionine and betaine correct hepatitis C virus induced inhibition of interferon signaling in vitro
Francois H. T. Duong, Verena Christen, Magdalena Filipowicz, Markus H. Heim – 23 March 2006 – Hepatitis C virus (HCV) infection is an important cause of chronic liver disease. Standard therapy, pegylated interferon α (pegIFNα) combined with ribavirin, results in a sustained response rate in approximately half of patients. The cause of treatment failure in the other half of the patients is unknown, but viral interference with IFNα signal transduction through the Jak‐STAT pathway might be an important factor.